Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 4,181–4,200 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Triamcinolone Acetonide Ointment USP, 0.1%, packaged in a) 15 grams tubes, NDC 52565-014-15; b) 80 grams tubes, NDC 52565-014-80; c) 1 lb (454 g) jars, NDC 52565-014-26; Rx only, Teligent Pharma, Inc., Buena, New Jersey 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL (60 grams) bottle, Rx only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-010-59.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Triamcinolone Acetonide Cream USP, 0.1%, packaged in a) 15 grams tubes, NDC 52565-056-15; b) 30 grams tubes, NDC 52565-056-30; c) 80 grams tubes, NDC 52565-056-80, d) 1 lb (454 g) jars, NDC 52565-056-26; Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Triamcinolone Acetonide Ointment USP, 0.5%, Net Wt. 15 grams tube, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-048-15.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Nystatin and Triamcinolone Acetonide Ointment, USP, packaged in a) 15 grams tubes, NDC 52565-042-15; b) 30 grams tubes, NDC 52565-042-30; c) 60 grams tubes, NDC 52565-042-60, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 oz) tube, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-008-14.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Cream, 4%, packaged in a) Net Wt. 15 grams tubes, NDC 52565-122-15; b) Net Wt. 30 grams tubes, NDC 52565-122-30; c) 5 x 5 gram tubes, NDC 52565-122-07; Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310; Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocortisone Butyrate Lotion, 0.1%, packaged in a) 2 fl oz (59 mL) bottles, NDC 52565-087-02; b) 4 fl oz (118 mL) bottles, NDC 52565-087-04, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-998-67.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocortisone Butyrate Lotion 0.1%, 4 fl. oz. (118 mL) bottle, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-159-04.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Halobetasol Propionate Ointment, 0.05%, packaged as a) 15 g tubes, NDC 52565-073-15; b) 50 g tubes, NDC 52565-073-51, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-033-50.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Gentamicin Sulfate Ointment USP 0.1%, packaged as a) 15 grams tube, NDC 52565-090-15; b) 30 grams tube, NDC 52565-090-30, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Gentamicin Sulfate Cream USP, 0.1%, packaged in a) 15 g tubes, NDC 52565-085-15, b) 30 g tubes, NDC 52565-085-30, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Fluocinonide Topical Solution USP, 0.05%, packaged in a) 20 mL bottles, NDC 52565-025-20; b) 60 mL bottles, NDC 52565-025-59, Rx only, Teligent Pharma, Inc., Buena, New Jersey 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Fluocinonide Gel USP, 0.05%, packaged in a) 15 g tubes, NDC 52565-054-15; b) 60 g tubes, NDC 52565-054-60; c) 30 g tubes, NDC 52565-054-30, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Fluocinonide Cream USP, 0.1%, 120 grams tube, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-079-11.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Econazole Nitrate Cream, 1%, packaged in a) 15 grams tubes, NDC 52565-022-15; b) 85 grams tubes, NDC 52565-022-85; c) 30 grams tubes, NDC 52565-022-30, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured for: SOLA Pharmaceuticals, LLC Baton Rouge, LA 70809, NDC 70512-031-60.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Diclofenac Sodium Topical Solution USP, 1.5% w/w, 5 fl. oz. (150 mL) bottles, Rx Only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70810, NDC 70512-025-05.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.